Beyond to Reunite Buy Buy Baby with Bed Bath Beyond Through Brand Rights Purchase Traders Bet on IonQ Micron Anduril as Potential US Government Stake Targets After Quantum Investments Nebius Shares Surge After ExOpenAI Employees Fund Discloses Stake Morgan Stanley Signals Potential Turnaround for Franklin Resources BEN AI ETF at 62 Attracts Attention as Alternative to HigherPriced Cerebras Stock SuratBased Anupam Rasayan India Plans Majority Stake Acquisition in Bliss GVS Pharma for Over 1360 Crore WM Q1 2026 Earnings Slight EPS Beat Amid Steady Operations Stock Edges Higher Almonty Industries Q1 2026 Earnings EPS Misses Estimates as Loss Widens Shares Decline Cathay General Bancorp CATY Q1 2026 Earnings Strong EPS Surprise of 2275 Drives Profit Beat Despite Stock Dip Diageo DEO Q1 2026 Earnings EPS Misses Estimates Amid Volume Pressures Stock Edges Higher ESE Q1 2026 Earnings EPS Beats Estimates Stock Rises 32 UTSI Q4 2019 Earnings Significant EPS Miss Highlights Operational Challenges Thor Industries THO Slips 18 as RV Demand Headwinds Persist BHFAO Preferred Shares Hold Steady at 1601 Amid Narrow Trading Range Silicon Laboratories Inc SLAB Edges Lower Consolidates Near Support at 207 MGRB Shows Modest Uptick as FixedIncome Security Holds Near Midpoint of Range Ribbon Communications RBBN Surges 528 as Shares Test Key Resistance Level US Consumer Sentiment Hits Record Low in May Amid Iran Conflict and Inflation Fears CNB Financial Corporation Q1 2026 Earnings EPS Beats Estimates by 74 as Stock Declines Eaton Vance Short Duration Diversified Income Fund EVG Slides Marginally as Market Weighs Income Strategies Ultra Clean Holdings UCTT Surges 471 as Semiconductor Sector Momentum Builds Guardforce AI GFAI Nears Key Support at 046 After Modest Decline Americas CarMart Inc CRMT Faces Headwinds as Shares Slide Below 12 Hudson Technologies HDSN Gains Ground as Seasonal Catalysts Emerge DHI Group Inc DHX Edges Higher Support Test Points to Potential Upside Blackrock MuniYield Quality Fund III Inc MYI Rallies 15 as YieldSeekers Return Nurix Therapeutics NRIX Holds Near Resistance as Biotech Sector Shows Signs of Life